drugset / Trial / NCT02564029
PF-06372865 in Subjects With Photosensitive Epilepsy
RandomizedCrossoverDouble-blindBasic science
Summary
PF-06372865 in subjects with photosensitive epilepsy
Timeline
- Start
- 2015-12-16
- Primary completion
- 2017-01-10
- Completion
- 2017-02-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darigabat | Small molecule | 17.5 mg | — |
| Subject | Darigabat | Small molecule | 52.5 mg | — |
| Comparator | Lorazepam | Small molecule | 2 mg | Oral |